CANC · Tema Oncology ETF
United States · RS rating 62 · As of 2026-10-14
| Price | 39.73 USD |
|---|---|
| 1-day change | +1.2% |
| RS rating (overall / 1M / 3M / 12M) | 62 / 39 / 55 / 84 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 39 / 62 / 29 |
| Industry group (rank) | Finance-ETF / ETN (48) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +12.2% |
| Market cap (USD) | – |